VEGFA and neoplasm: Only a few case reports have described response in tumour thrombus when immunotherapy was used in the neoadjuvant setting [10–13] and response rates in tumour thrombus from combination IO or IO/anti-VEGF TKI as compared to anti-VEGF TKI alone are unknown, and should be studied in larger observational studies and/or randomised trials.